- Email: [email protected]
Prenatal Screening
PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version www.pdflib.com – [email protected]
menopausal symptoms [ACOG practice bulletin]. Washington, DC: Author. American College of Obstetricians and Gynecologists. (2002). Questions and answers on hormone therapy. Washington, DC: Author. Cockey, C. D. (2003). Breast cancer risk from HRT confirmed. AWHONN Lifelines, 7(1), 16-20. George, S. A. (2002). The menopause experience: A woman’s perspective. Journal of Obstetric, Gynecologic, and Neonatal Nursing, 31, 77-85. MacPherson, L. (1995). Going to the source: Women reclaim menopause. Feminist Studies, 21(2), 347-356. Mendelsohn, M., & Karas, R. (1999). The protective effects of estrogen on the cardiovascular system. New England Journal of Medicine, 340, 1801-1811. Schneider, D. L., Barrett-Connor, E. L., & Morton, D. J. (1997). Timing of postmenopausal estrogen for optimal bone mineral density. The Rancho Bernado Study. Journal of the American Medical Association, 277, 543-547. Stampfer, M. J., & Colditz, G. A. (1991). Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence. Preventive Medicine, 20, 47-63. Writing Group for the PEPI Trial. (1995). The effects of estrogen or estrogen-progestin regimens on heart disease risk factors in postmenopausal women. Journal of the American Medical Association, 273, 199-208. Writing Group of the Women’s Health Initiative. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the WHI randomized clinical trial. Journal of the American Medical Association, 288, 1-24.
Compliments for Changes, Quality
M
y thanks for the changes outlined in your editorial (January/February 2003 JOGNN). I applaud your groundbreaking efforts to publish Carol Sakala’s column simultaneously in two different journals, the better to
286 JOGNN
reach the similar yet distinct audiences for both. Elimination of the “alphabet soup” from author entries should help my students who are struggling with APA style. The ISI indexing is a real tribute to the quality of JOGNN and should serve to increase access to nursing knowledge for other disciplines. As a charter member of NAACOG/AWHONN and a reader of this journal from Volume 1, Issue 1, I have been so impressed by the increasing maturity and scientific sophistication of our organization and its premier publication. Thank you for keeping the content current, relevant, and essential to the informed practice of nursing. Sharon Jacques, RN, PhD Candler, NC
Prenatal Screening
Thank you for a well-constructed and explained research
study on prenatal smoking and alterations in newborn heart rate during transition (“Prenatal Smoking and Alterations in Newborn Heart Rate During Transition,” November/ December 2002 JOGNN). As a current multivariate analysis student, I found the explanations by the authors about their statistics useful and instructive. Thank you for demystifying research statistics for the novice! Buried in the limitations section of the study, I found perhaps an equally intriguing research question. The authors implied that nurses used their clinical judgment to decide who needed drug screening and who did not. My professors tell me that clinical decision making is a hot topic. I would like to see a study of how nurses decide who “needs” drug screening and how accurate they are. Suzan Kardong-Edgren, MS, RNC Flower Mound, TX
Volume 32, Number 3
menopausal symptoms [ACOG practice bulletin]. Washington, DC: Author. American College of Obstetricians and Gynecologists. (2002). Questions and answers on hormone therapy. Washington, DC: Author. Cockey, C. D. (2003). Breast cancer risk from HRT confirmed. AWHONN Lifelines, 7(1), 16-20. George, S. A. (2002). The menopause experience: A woman’s perspective. Journal of Obstetric, Gynecologic, and Neonatal Nursing, 31, 77-85. MacPherson, L. (1995). Going to the source: Women reclaim menopause. Feminist Studies, 21(2), 347-356. Mendelsohn, M., & Karas, R. (1999). The protective effects of estrogen on the cardiovascular system. New England Journal of Medicine, 340, 1801-1811. Schneider, D. L., Barrett-Connor, E. L., & Morton, D. J. (1997). Timing of postmenopausal estrogen for optimal bone mineral density. The Rancho Bernado Study. Journal of the American Medical Association, 277, 543-547. Stampfer, M. J., & Colditz, G. A. (1991). Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence. Preventive Medicine, 20, 47-63. Writing Group for the PEPI Trial. (1995). The effects of estrogen or estrogen-progestin regimens on heart disease risk factors in postmenopausal women. Journal of the American Medical Association, 273, 199-208. Writing Group of the Women’s Health Initiative. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the WHI randomized clinical trial. Journal of the American Medical Association, 288, 1-24.
Compliments for Changes, Quality
M
y thanks for the changes outlined in your editorial (January/February 2003 JOGNN). I applaud your groundbreaking efforts to publish Carol Sakala’s column simultaneously in two different journals, the better to
286 JOGNN
reach the similar yet distinct audiences for both. Elimination of the “alphabet soup” from author entries should help my students who are struggling with APA style. The ISI indexing is a real tribute to the quality of JOGNN and should serve to increase access to nursing knowledge for other disciplines. As a charter member of NAACOG/AWHONN and a reader of this journal from Volume 1, Issue 1, I have been so impressed by the increasing maturity and scientific sophistication of our organization and its premier publication. Thank you for keeping the content current, relevant, and essential to the informed practice of nursing. Sharon Jacques, RN, PhD Candler, NC
Prenatal Screening
Thank you for a well-constructed and explained research
study on prenatal smoking and alterations in newborn heart rate during transition (“Prenatal Smoking and Alterations in Newborn Heart Rate During Transition,” November/ December 2002 JOGNN). As a current multivariate analysis student, I found the explanations by the authors about their statistics useful and instructive. Thank you for demystifying research statistics for the novice! Buried in the limitations section of the study, I found perhaps an equally intriguing research question. The authors implied that nurses used their clinical judgment to decide who needed drug screening and who did not. My professors tell me that clinical decision making is a hot topic. I would like to see a study of how nurses decide who “needs” drug screening and how accurate they are. Suzan Kardong-Edgren, MS, RNC Flower Mound, TX
Volume 32, Number 3